Invention Grant
- Patent Title: Implantable device for sustained release of a macromolecular drug compound
-
Application No.: US16416328Application Date: 2019-05-20
-
Publication No.: US11690806B2Publication Date: 2023-07-04
- Inventor: Christian Schneider
- Applicant: Celanese EVA Performance Polymers Corporation
- Applicant Address: US TX Irving
- Assignee: Celanese EVA Performance Polymers LLC
- Current Assignee: Celanese EVA Performance Polymers LLC
- Current Assignee Address: US TX Irving
- Agency: Dority & Manning, P.A.
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K49/04 ; A61K38/47 ; A61K38/39

Abstract:
An implantable device for delivery of a macromolecular drug compound is provided. The device comprises a core having an outer surface and a membrane layer positioned adjacent to the outer surface of the core. The core comprises a core polymer matrix within which is dispersed a drug compound having a molecular weight of about 0.5 kDa or more, the polymer matrix containing a hydrophobic polymer. Further, the membrane layer comprises a membrane polymer matrix within which the macromolecular drug compound is optionally dispersed. The membrane polymer matrix contains a hydrophobic polymer in combination with a hydrophilic compound, and the weight ratio of the hydrophobic polymer to the hydrophilic compound within the membrane polymer matrix ranges from about 0.25 to about 200.
Information query